Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 37,799	$ 23,854
General and administrative	11,469	8,236
Total operating expenses	49,268	32,090
Loss from operations	(49,268)	(32,090)
Other income (expense):
Interest income	14	66
Interest expense	(849)
Other expense	(8)
Total other income (expense), net	(843)	66
Net loss	$ (50,111)	$ (32,024)
Net loss per common share, basic and diluted	$ (1.31)	$ (0.87)
Weighted average common shares outstanding, basic and diluted	38,174,717	36,992,377